Drug pre-targeting by means of bispecific antibodies and hapten constructs comprising a carrier peptide and the active agent (s)

Details for Australian Patent Application No. 2003227939 (hide)

Owner Immunomedics, Inc.

Inventors Hansen, Hans; Qu, Zhengxing; McBride, William J.; Goldenberg, David M.; Leung, Shui-on

Agent Davies Collison Cave

Pub. Number AU-B-2003227939

PCT Number PCT/GB03/02110

PCT Pub. Number WO2003/097105

Priority 10/150,654 17.05.02 US

Filing date 16 May 2003

Wipo publication date 2 December 2003

Acceptance publication date 29 November 2007

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 10/150,654 17.05.02 US

29 January 2004 Application Open to Public Inspection

  Published as AU-B-2003227939

29 November 2007 Application Accepted

  Published as AU-B-2003227939

3 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003227940-VISCOMETERS

2003227938-PROCESSES, COMPOSITIONS AND COMPOUNDS